Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$5.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 17 most recent Form 4 transactions.
| $243K |
| -47.8% |
| Open the original filing on SEC.gov |
| Oct 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 2,100 | $92.70 | $194.7K | -27.8% | Open the original filing on SEC.gov |
| Oct 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 7,228 | $91.35 | $660.3K | -48.9% | Open the original filing on SEC.gov |
| Oct 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 16,605 | $90.35 | $1.5M | -52.9% | Open the original filing on SEC.gov |
| Oct 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 400 | $89.24 | $35.7K | -1.3% | Open the original filing on SEC.gov |
| Oct 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷ | 28,933 | $14.50 | $419.5K | +1,017% | Open the original filing on SEC.gov |
| Sep 2 | SYRE | Spyre Therapeutics, Inc. | MEXER◷◆ | 400 | — | — | — | Open the original filing on SEC.gov |
| Sep 2 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 400 | $90.00 | $36K | -12.3% | Open the original filing on SEC.gov |
| Sep 2 | SYRE | Spyre Therapeutics, Inc. | MEXER◷ | 400 | $14.50 | $5.8K | +14.1% | Open the original filing on SEC.gov |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷◆ | 27,999 | — | — | — | Open the original filing on SEC.gov |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 400 | $89.38 | $35.8K | -12.3% | Open the original filing on SEC.gov |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 6,206 | $88.17 | $547.2K | -65.7% | Open the original filing on SEC.gov |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 16,548 | $87.20 | $1.4M | -63.6% | Open the original filing on SEC.gov |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 4,845 | $86.40 | $418.6K | -15.7% | Open the original filing on SEC.gov |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷ | 27,999 | $14.50 | $406K | +984.1% | Open the original filing on SEC.gov |
| Jan 9 | SYRE | Spyre Therapeutics, Inc. | AGRANT◆ | 140,000 | — | — | — | Open the original filing on SEC.gov |